283 related articles for article (PubMed ID: 11034379)
1. The CD85/LIR-1/ILT2 inhibitory receptor is expressed by all human T lymphocytes and down-regulates their functions.
Saverino D; Fabbi M; Ghiotto F; Merlo A; Bruno S; Zarcone D; Tenca C; Tiso M; Santoro G; Anastasi G; Cosman D; Grossi CE; Ciccone E
J Immunol; 2000 Oct; 165(7):3742-55. PubMed ID: 11034379
[TBL] [Abstract][Full Text] [Related]
2. CD85/LIR-1/ILT2 and CD152 (cytotoxic T lymphocyte antigen 4) inhibitory molecules down-regulate the cytolytic activity of human CD4+ T-cell clones specific for Mycobacterium tuberculosis.
Merlo A; Saverino D; Tenca C; Grossi CE; Bruno S; Ciccone E
Infect Immun; 2001 Oct; 69(10):6022-9. PubMed ID: 11553539
[TBL] [Abstract][Full Text] [Related]
3. Dual effect of CD85/leukocyte Ig-like receptor-1/Ig-like transcript 2 and CD152 (CTLA-4) on cytokine production by antigen-stimulated human T cells.
Saverino D; Merlo A; Bruno S; Pistoia V; Grossi CE; Ciccone E
J Immunol; 2002 Jan; 168(1):207-15. PubMed ID: 11751964
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of leukocyte receptor complex-encoded Ig-like receptors correlates with the transition from effector to memory CTL.
Young NT; Uhrberg M; Phillips JH; Lanier LL; Parham P
J Immunol; 2001 Mar; 166(6):3933-41. PubMed ID: 11238638
[TBL] [Abstract][Full Text] [Related]
5. CTLA-4 (CD152) inhibits the specific lysis mediated by human cytolytic T lymphocytes in a clonally distributed fashion.
Saverino D; Tenca C; Zarcone D; Merlo A; Megiovanni AM; Valle MT; Manca F; Grossi CE; Ciccone E
J Immunol; 1999 Jan; 162(2):651-8. PubMed ID: 9916682
[TBL] [Abstract][Full Text] [Related]
6. Ig-like transcript 2 (ILT2)/leukocyte Ig-like receptor 1 (LIR1) inhibits TCR signaling and actin cytoskeleton reorganization.
Dietrich J; Cella M; Colonna M
J Immunol; 2001 Feb; 166(4):2514-21. PubMed ID: 11160312
[TBL] [Abstract][Full Text] [Related]
7. Specific recognition of the viral protein UL18 by CD85j/LIR-1/ILT2 on CD8+ T cells mediates the non-MHC-restricted lysis of human cytomegalovirus-infected cells.
Saverino D; Ghiotto F; Merlo A; Bruno S; Battini L; Occhino M; Maffei M; Tenca C; Pileri S; Baldi L; Fabbi M; Bachi A; De Santanna A; Grossi CE; Ciccone E
J Immunol; 2004 May; 172(9):5629-37. PubMed ID: 15100307
[TBL] [Abstract][Full Text] [Related]
8. Engagement of ILT2/CD85j in Sézary syndrome cells inhibits their CD3/TCR signaling.
Nikolova M; Musette P; Bagot M; Boumsell L; Bensussan A
Blood; 2002 Aug; 100(3):1019-25. PubMed ID: 12130517
[TBL] [Abstract][Full Text] [Related]
9. Identification of the CD85 antigen as ILT2, an inhibitory MHC class I receptor of the immunoglobulin superfamily.
Banham AH; Colonna M; Cella M; Micklem KJ; Pulford K; Willis AC; Mason DY
J Leukoc Biol; 1999 Jun; 65(6):841-5. PubMed ID: 10380908
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of cytolytic functions of human Vδ2-γ T lymphocytes through engagement of ILT2 expressed by tumor target cells.
Harly C; Peyrat MA; Netzer S; Déchanet-Merville J; Bonneville M; Scotet E
Blood; 2011 Mar; 117(10):2864-73. PubMed ID: 21233315
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of the natural killer cell inhibitory receptor CD85j/ILT2 on antigen-specific effector CD8 T cells and its impact on CD8 T-cell function.
Ince MN; Harnisch B; Xu Z; Lee SK; Lange C; Moretta L; Lederman M; Lieberman J
Immunology; 2004 Aug; 112(4):531-42. PubMed ID: 15270723
[TBL] [Abstract][Full Text] [Related]
12. CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes.
Azuma M; Cayabyab M; Buck D; Phillips JH; Lanier LL
J Exp Med; 1992 Feb; 175(2):353-60. PubMed ID: 1370679
[TBL] [Abstract][Full Text] [Related]
13. Disparate cytotoxic activity of nickel-specific CD8+ and CD4+ T cell subsets against keratinocytes.
Traidl C; Sebastiani S; Albanesi C; Merk HF; Puddu P; Girolomoni G; Cavani A
J Immunol; 2000 Sep; 165(6):3058-64. PubMed ID: 10975816
[TBL] [Abstract][Full Text] [Related]
14. Patterns of costimulation of T cell clones by cross-linking CD3, CD4/CD8, and class I MHC molecules.
Wacholtz MC; Patel SS; Lipsky PE
J Immunol; 1989 Jun; 142(12):4201-12. PubMed ID: 2470819
[TBL] [Abstract][Full Text] [Related]
15. HLA class I molecules regulate IFN-gamma production induced in NK cells by target cells, viral products, or immature dendritic cells through the inhibitory receptor ILT2/CD85j.
Morel E; Bellón T
J Immunol; 2008 Aug; 181(4):2368-81. PubMed ID: 18684926
[TBL] [Abstract][Full Text] [Related]
16. High expression of the ILT2 (LIR-1) inhibitory receptor for major histocompatibility complex class I molecules on clonal expansions of T large granular lymphocytes in asymptomatic patients.
Casado LF; Granados E; Algara P; Navarro F; Martinez-Frejo MC; López-Botet M
Haematologica; 2001 May; 86(5):457-63. PubMed ID: 11410407
[TBL] [Abstract][Full Text] [Related]
17. The role of Ca2+ and Mg2+ in the cytotoxic T lymphocyte reaction and in the secretion of N alpha-benzyloxycarbonyl-L-lysine thiobenzyl ester-serine esterase by human T cell clones.
Blanchard D; Aubry JP; de Vries JE; Spits H
J Immunol; 1989 Apr; 142(7):2173-80. PubMed ID: 2564406
[TBL] [Abstract][Full Text] [Related]
18. T cell clones expressing the natural killer cell-related p58 receptor molecule display heterogeneity in phenotypic properties and p58 function.
Ferrini S; Cambiaggi A; Meazza R; Sforzini S; Marciano S; Mingari MC; Moretta L
Eur J Immunol; 1994 Oct; 24(10):2294-8. PubMed ID: 7925558
[TBL] [Abstract][Full Text] [Related]
19. Functional modulation of expanded CD8+ synovial fluid T cells by NK cell receptor expression in HLA-B27-associated reactive arthritis.
Dulphy N; Rabian C; Douay C; Flinois O; Laoussadi S; Kuipers J; Tamouza R; Charron D; Toubert A
Int Immunol; 2002 May; 14(5):471-9. PubMed ID: 11978777
[TBL] [Abstract][Full Text] [Related]
20. CD94/NKG2 expression does not inhibit cytotoxic function of lymphocytic choriomeningitis virus-specific CD8+ T cells.
Miller JD; Peters M; Oran AE; Beresford GW; Harrington L; Boss JM; Altman JD
J Immunol; 2002 Jul; 169(2):693-701. PubMed ID: 12097371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]